Skip to content

Opening book details…

About this Medicine article

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups by Passiglia, Francesco (author);Galvano, Antonio (author);Gristina, Valerio (author);Barraco, Nadia (author);Castiglia, Marta (author);Perez, Alessandro (author);La Mantia, Maria (author);Russo, Antonio (author);Bazan, Viviana (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Passiglia, Francesco (author);Galvano, Antonio (author);Gristina, Valerio (author);Barraco, Nadia (author);Castiglia, Marta (author);Perez, Alessandro (author);La Mantia, Maria (author);Russo, Antonio (author);Bazan, Viviana (author)
Publisher
AME Publishing Company
Published
2021
Field
Medicine (Health Sciences)

More by Passiglia, Francesco (author);Galvano, Antonio (author);Gristina, Valerio (author);Barraco, Nadia (author);Castiglia, Marta (author);Perez, Alessandro (author);La Mantia, Maria (author);Russo, Antonio (author);Bazan, Viviana (author)

Browse all works by Passiglia, Francesco (author);Galvano, Antonio (author);Gristina, Valerio (author);Barraco, Nadia (author);Castiglia, Marta (author);Perez, Alessandro (author);La Mantia, Maria (author);Russo, Antonio (author);Bazan, Viviana (author)